Gut microbes
Cure8 research brief
Why This Matters
The work suggests soluble factors present in fecal filtrates from active UC patients can provoke proinflammatory responses in a controlled intestine-on-chip model, supporting the idea that microbiome-derived metabolites or molecules may contribute to UC pathogenesis and could be targets for future research or biomarkers.
Who Should Pay Attention
Researchers, translational scientists, clinicians interested in UC pathogenesis, microbiome and organ-on-chip technology.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
Researchers used a microphysiological intestine-on-chip (IoC) model with immune components to test sterile fecal microbiome filtrate (FMF) from people with active ulcerative colitis (UC), UC in remission, and non-UC controls.
FMF from active UC patients triggered a time-dependent increase in proinflammatory cytokines (IL‑1β, IL‑6, IL‑8, IL‑23, MCP‑1) in the vascular compartment and increased luminal-to-vascular permeability.
An AI-driven image pipeline quantified epithelial damage, reduced tissue thickness, lower endothelial cell density, and altered macrophage morphology after FMF exposure; some changes occurred regardless of disease activity.
These experiments are in a simplified IoC model (not a whole human gut) and use sterile filtrates rather than live microbes, so findings point to soluble FMF-derived factors that can provoke inflammation in this controlled system but do not establish causation in patients.
The study establishes standardized IoC imaging metrics useful for further mechanistic work.
Keep In Mind
Findings come from a simplified, immunocompetent intestine-on-chip model and sterile fecal filtrates; they require additional mechanistic and in vivo validation before clinical implications can be drawn.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationGut microbes
AuthorsTobias Schaal, Parastoo Akbarimoghaddam, Valentin D Wegner +9 more
InstitutionDepartment of Internal Medicine IV, Jena University Hospital, Jena, Germany.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedJul 28, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Human gut flagellome profiling using FlaPro reveals TLR5-related phenotype-specific alterations in IBD.
This paper links specific features of the gut bacterial flagellome to TLR5-driven immune activation and reports a disease-associated shift in flagellin profiles in Crohn’s disease and ulcerative colitis, suggesting...
Machine Learning Model Identifies Gut Biomarkers That May Help Diagnose IBD Patients
This study suggests machine learning of stool microbiome data could eventually help distinguish IBD (especially Crohn’s) from healthy people and some other bowel or systemic conditions.
Artificial Intelligence in the Nutritional Management of Inflammatory Bowel Disease: A Scoping Review.
AI could help identify dietary patterns, predict which patients might benefit from specific nutrition approaches, and provide personalized nutrition support — potentially improving inflammation and gut microbiome...